
Farley J. Abad
Examiner (ID: 14201, Phone: (571)270-3425 , Office: P/2181 )
| Most Active Art Unit | 2181 |
| Art Unit(s) | 2181 |
| Total Applications | 1076 |
| Issued Applications | 864 |
| Pending Applications | 101 |
| Abandoned Applications | 140 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 626790
[patent_doc_number] => 07135173
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-11-14
[patent_title] => 'Antiviral activity of Shiga toxin'
[patent_app_type] => utility
[patent_app_number] => 10/325664
[patent_app_country] => US
[patent_app_date] => 2002-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 20956
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/135/07135173.pdf
[firstpage_image] =>[orig_patent_app_number] => 10325664
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/325664 | Antiviral activity of Shiga toxin | Dec 17, 2002 | Issued |
| 10/311580 | Assembly of wild-type and chimeric influenza virus-like particles (vlps) | Dec 15, 2002 | Abandoned |
Array
(
[id] => 6633021
[patent_doc_number] => 20030211467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Methods and compositions for detecting hepatitis E virus'
[patent_app_type] => new
[patent_app_number] => 10/319745
[patent_app_country] => US
[patent_app_date] => 2002-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 40273
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20030211467.pdf
[firstpage_image] =>[orig_patent_app_number] => 10319745
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/319745 | Methods and compositions for detecting hepatitis E virus | Dec 12, 2002 | Abandoned |
Array
(
[id] => 6741006
[patent_doc_number] => 20030158375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'G-CSF polypeptides and conjugates'
[patent_app_type] => new
[patent_app_number] => 10/318966
[patent_app_country] => US
[patent_app_date] => 2002-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 35742
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20030158375.pdf
[firstpage_image] =>[orig_patent_app_number] => 10318966
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/318966 | G-CSF polypeptides and conjugates | Dec 12, 2002 | Abandoned |
Array
(
[id] => 6830297
[patent_doc_number] => 20030181355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Method for inhibition of viral infection'
[patent_app_type] => new
[patent_app_number] => 10/317644
[patent_app_country] => US
[patent_app_date] => 2002-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10775
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20030181355.pdf
[firstpage_image] =>[orig_patent_app_number] => 10317644
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/317644 | Method for inhibition of viral infection | Dec 10, 2002 | Abandoned |
Array
(
[id] => 6639466
[patent_doc_number] => 20030212039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Method for preventing vascular disease'
[patent_app_type] => new
[patent_app_number] => 10/309761
[patent_app_country] => US
[patent_app_date] => 2002-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14582
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20030212039.pdf
[firstpage_image] =>[orig_patent_app_number] => 10309761
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/309761 | Method for preventing vascular disease | Dec 3, 2002 | Abandoned |
Array
(
[id] => 6639466
[patent_doc_number] => 20030212039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Method for preventing vascular disease'
[patent_app_type] => new
[patent_app_number] => 10/309761
[patent_app_country] => US
[patent_app_date] => 2002-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14582
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20030212039.pdf
[firstpage_image] =>[orig_patent_app_number] => 10309761
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/309761 | Method for preventing vascular disease | Dec 3, 2002 | Abandoned |
Array
(
[id] => 6702150
[patent_doc_number] => 20030225030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-04
[patent_title] => 'Non-liquid vitamin compositions'
[patent_app_type] => new
[patent_app_number] => 10/309802
[patent_app_country] => US
[patent_app_date] => 2002-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14575
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0225/20030225030.pdf
[firstpage_image] =>[orig_patent_app_number] => 10309802
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/309802 | Non-liquid vitamin compositions | Dec 3, 2002 | Abandoned |
Array
(
[id] => 6770410
[patent_doc_number] => 20030216350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => 'Method for prevention of neuropsychiatric disorders'
[patent_app_type] => new
[patent_app_number] => 10/309752
[patent_app_country] => US
[patent_app_date] => 2002-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14581
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20030216350.pdf
[firstpage_image] =>[orig_patent_app_number] => 10309752
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/309752 | Method for prevention of neuropsychiatric disorders | Dec 3, 2002 | Abandoned |
Array
(
[id] => 6702150
[patent_doc_number] => 20030225030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-04
[patent_title] => 'Non-liquid vitamin compositions'
[patent_app_type] => new
[patent_app_number] => 10/309802
[patent_app_country] => US
[patent_app_date] => 2002-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14575
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0225/20030225030.pdf
[firstpage_image] =>[orig_patent_app_number] => 10309802
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/309802 | Non-liquid vitamin compositions | Dec 3, 2002 | Abandoned |
Array
(
[id] => 6770410
[patent_doc_number] => 20030216350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => 'Method for prevention of neuropsychiatric disorders'
[patent_app_type] => new
[patent_app_number] => 10/309752
[patent_app_country] => US
[patent_app_date] => 2002-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14581
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20030216350.pdf
[firstpage_image] =>[orig_patent_app_number] => 10309752
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/309752 | Method for prevention of neuropsychiatric disorders | Dec 3, 2002 | Abandoned |
Array
(
[id] => 6664547
[patent_doc_number] => 20030203873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-30
[patent_title] => 'Method for treatment of neuropsychiatric disorders'
[patent_app_type] => new
[patent_app_number] => 10/309748
[patent_app_country] => US
[patent_app_date] => 2002-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14571
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20030203873.pdf
[firstpage_image] =>[orig_patent_app_number] => 10309748
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/309748 | Method for treatment of neuropsychiatric disorders | Dec 3, 2002 | Abandoned |
Array
(
[id] => 6711535
[patent_doc_number] => 20030171284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Derivatives of growth hormone and related proteins, and methods of use thereof'
[patent_app_type] => new
[patent_app_number] => 10/298148
[patent_app_country] => US
[patent_app_date] => 2002-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37953
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20030171284.pdf
[firstpage_image] =>[orig_patent_app_number] => 10298148
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/298148 | Derivatives of growth hormone and related proteins, and methods of use thereof | Nov 14, 2002 | Issued |
Array
(
[id] => 7363764
[patent_doc_number] => 20040091851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-13
[patent_title] => 'HCV peptide compositions'
[patent_app_type] => new
[patent_app_number] => 10/291734
[patent_app_country] => US
[patent_app_date] => 2002-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 166
[patent_figures_cnt] => 166
[patent_no_of_words] => 73129
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20040091851.pdf
[firstpage_image] =>[orig_patent_app_number] => 10291734
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/291734 | HCV peptide compositions | Nov 11, 2002 | Abandoned |
Array
(
[id] => 6765247
[patent_doc_number] => 20030099645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-29
[patent_title] => 'Naturally occuring IgM antibodies that bind to membrane receptors on lymphocytes'
[patent_app_type] => new
[patent_app_number] => 10/292002
[patent_app_country] => US
[patent_app_date] => 2002-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13041
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20030099645.pdf
[firstpage_image] =>[orig_patent_app_number] => 10292002
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/292002 | Naturally occuring IgM antibodies that bind to membrane receptors on lymphocytes | Nov 6, 2002 | Abandoned |
Array
(
[id] => 971866
[patent_doc_number] => 06936251
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-08-30
[patent_title] => 'Peptide reagent for the detection of human cytomegalovirus (CMV)'
[patent_app_type] => utility
[patent_app_number] => 10/288220
[patent_app_country] => US
[patent_app_date] => 2002-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 8256
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/936/06936251.pdf
[firstpage_image] =>[orig_patent_app_number] => 10288220
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/288220 | Peptide reagent for the detection of human cytomegalovirus (CMV) | Nov 4, 2002 | Issued |
Array
(
[id] => 6696374
[patent_doc_number] => 20030108568
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-12
[patent_title] => 'Long lasting synthetic glucagon-like peptide {GLP-1}'
[patent_app_type] => new
[patent_app_number] => 10/288340
[patent_app_country] => US
[patent_app_date] => 2002-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20390
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20030108568.pdf
[firstpage_image] =>[orig_patent_app_number] => 10288340
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/288340 | Long lasting synthetic glucagon-like peptide {GLP-1} | Nov 3, 2002 | Issued |
Array
(
[id] => 1096286
[patent_doc_number] => 06821949
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-11-23
[patent_title] => 'Long lasting synthetic glucagon-like peptide (GLP-1)'
[patent_app_type] => B2
[patent_app_number] => 10/287892
[patent_app_country] => US
[patent_app_date] => 2002-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21975
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/821/06821949.pdf
[firstpage_image] =>[orig_patent_app_number] => 10287892
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/287892 | Long lasting synthetic glucagon-like peptide (GLP-1) | Nov 3, 2002 | Issued |
Array
(
[id] => 7025357
[patent_doc_number] => 20050019751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Screening for hepatitis c virus entry inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/494555
[patent_app_country] => US
[patent_app_date] => 2002-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8875
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20050019751.pdf
[firstpage_image] =>[orig_patent_app_number] => 10494555
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/494555 | Screening for hepatitis c virus entry inhibitors | Oct 31, 2002 | Abandoned |
| 10/281341 | Activation of HCV-specific T cells | Oct 24, 2002 | Abandoned |